104 related articles for article (PubMed ID: 10376044)
1. Lyme disease vaccine safe for all?
Rahn DW
Postgrad Med; 1999 Jun; 105(7):21. PubMed ID: 10376044
[No Abstract] [Full Text] [Related]
2. Availability of Lyme disease vaccine.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1999 Jan; 48(2):35-6, 43. PubMed ID: 9933128
[TBL] [Abstract][Full Text] [Related]
3. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group.
Steere AC; Sikand VK; Meurice F; Parenti DL; Fikrig E; Schoen RT; Nowakowski J; Schmid CH; Laukamp S; Buscarino C; Krause DS
N Engl J Med; 1998 Jul; 339(4):209-15. PubMed ID: 9673298
[TBL] [Abstract][Full Text] [Related]
4. Borrelia burgdorferi outer surface protein A vaccine: importance, role, and value.
Sigal LH
J Pediatr; 1999 Nov; 135(5):539-41. PubMed ID: 10547238
[No Abstract] [Full Text] [Related]
5. From the Food and Drug Administration.
Nightingale SL
JAMA; 1999 Feb; 281(5):408. PubMed ID: 9952188
[No Abstract] [Full Text] [Related]
6. [Lyme borreliosis--vaccines in the "pipeline"].
Kramer M
MMW Fortschr Med; 1999 Jun; 141(25):52-3. PubMed ID: 10897909
[No Abstract] [Full Text] [Related]
7. Immunization against Lyme disease--an important first step.
Steigbigel RT; Benach JL
N Engl J Med; 1998 Jul; 339(4):263-4. PubMed ID: 9673306
[No Abstract] [Full Text] [Related]
8. The recombinant outer surface protein A (lipOspA) of Borrelia burgdorferi: a Lyme disease vaccine.
Wallich R; Kramer MD; Simon MM
Infection; 1996; 24(5):396-7. PubMed ID: 8923055
[No Abstract] [Full Text] [Related]
9. A recombinant vaccine for Lyme disease.
Wallich R; Kramer MD; Simon MM
Behring Inst Mitt; 1994 Dec; (95):106-8. PubMed ID: 7755503
[TBL] [Abstract][Full Text] [Related]
10. Anti-OspA antibody reduces reservoir competence of mice for Borrelia burgdorferi, the agent of Lyme disease.
Brunet LR; Katavolos P; Spielman A; Telford SR
Med Vet Entomol; 1997 Apr; 11(2):198-200. PubMed ID: 9226653
[No Abstract] [Full Text] [Related]
11. Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against lyme disease in healthy children and adolescents: a randomized controlled trial.
Sikand VK; Halsey N; Krause PJ; Sood SK; Geller R; Van Hoecke C; Buscarino C; Parenti D;
Pediatrics; 2001 Jul; 108(1):123-8. PubMed ID: 11433064
[TBL] [Abstract][Full Text] [Related]
12. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium.
Sigal LH; Zahradnik JM; Lavin P; Patella SJ; Bryant G; Haselby R; Hilton E; Kunkel M; Adler-Klein D; Doherty T; Evans J; Molloy PJ; Seidner AL; Sabetta JR; Simon HJ; Klempner MS; Mays J; Marks D; Malawista SE
N Engl J Med; 1998 Jul; 339(4):216-22. PubMed ID: 9673299
[TBL] [Abstract][Full Text] [Related]
13. Lyme disease vaccine cleared for marketing.
Miller JL
Am J Health Syst Pharm; 1999 Feb; 56(3):206. PubMed ID: 10030501
[No Abstract] [Full Text] [Related]
14. Detection of Lyme disease after OspA vaccine.
Schutzer SE; Luan J; Coyle PK
N Engl J Med; 1997 Sep; 337(11):794-5. PubMed ID: 9289653
[No Abstract] [Full Text] [Related]
15. An effective vaccine against Lyme disease.
Crooy P; Lobet Y
J Biotechnol; 2000 Jan; 76(2-3):261-3. PubMed ID: 10656342
[No Abstract] [Full Text] [Related]
16. Lyme disease vaccine.
Schofield DH; Parenti D
JAMA; 2000 Jan; 283(2):199; author reply 200. PubMed ID: 10634331
[No Abstract] [Full Text] [Related]
17. Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine.
Keller D; Koster FT; Marks DH; Hosbach P; Erdile LF; Mays JP
JAMA; 1994 Jun; 271(22):1764-8. PubMed ID: 8196120
[TBL] [Abstract][Full Text] [Related]
18. Lyme disease vaccine.
Gerber MA
Pediatr Infect Dis J; 1999 Sep; 18(9):825-6. PubMed ID: 10493347
[No Abstract] [Full Text] [Related]
19. Prophylactic vaccination against Lyme borreliosis for man and dogs and new strategies to treat established B. burgdorferi infections.
Wallich R; Jahraus O; Simon MM
Int J Med Microbiol; 2002 Jun; 291 Suppl 33():147-9. PubMed ID: 12141739
[No Abstract] [Full Text] [Related]
20. Reactogenicity and immunogenicity of a Lyme disease vaccine in children 2-5 years old.
Beran J; De Clercq N; Dieussaert I; Van Hoecke C
Clin Infect Dis; 2000 Dec; 31(6):1504-7. PubMed ID: 11096024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
